AnalyzeDirect Klawitter J, McFann K, Pennington AT, Wang W, Klawitter J, Christians U, Schrier RW, Gitomer B, Cadnapaphornchai MA. Pravastatin therapy and biomarker changes in children and young adults with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. July 2015.
Publication Date
July 2015
How Analyze was Used
“DICOM images were deidentified and TKV was measured by stereology … (Analyze 9.0 …) by a single analyst who had no knowledge of the patient’s status.”
Keywords
Adolescent
Angiotensin-Converting Enzyme Inhibitors
Biological Markers
Child
Cyclooxygenase 1
Double-Blind Method
Humans
Hydroxyeicosatetraenoic Acids
Hydroxyoctadecadienoic Acid
Inflammation
Kidney
Linear Models
Linoleic Acids
Lipoxygenase
Mass spectrometry
Nephrology
Oxidative Stress
Polycystic Kidney, Autosomal Dominant
Pravastatin
Young Adult
Author Affiliation(s)
Division of Renal Diseases and Hypertension, University of Colorado, Aurora, CO, US. (JelenaK, KM, WW, RWS, BG, MAC)
Department of Anesthesiology, University of Colorado, Aurora, CO, US. (JelenaK, ATP, JostK, UC)
Department of Pediatrics, University of Colorado, Aurora, CO, US. (MAC)
ID# 3023
Tags: Adolescent, Angiotensin-Converting Enzyme Inhibitors, Autosomal Dominant Polycystic Kidney, Biological Markers, Child, Cyclooxygenase 1, Double-Blind Method, Humans, Hydroxyeicosatetraenoic Acids, Hydroxyoctadecadienoic Acid, Inflammation, Kidney, Linear Models, Linoleic Acids, Lipoxygenase, Mass Spectrometry, Nephrology, Oxidative Stress, Pravastatin, Young Adult